MedPath

Assessment of the Benefits of Adapted Physical Activity in Pediatric Hemodialysis Patients

Not Applicable
Not yet recruiting
Conditions
Hemodialysis
Registration Number
NCT07118007
Lead Sponsor
Hospices Civils de Lyon
Brief Summary

Children, adolescents, and young adults undergoing pediatric hemodialysis often experience functional limitations in daily life. Their level of physical activity is generally lower than that of healthy peers of the same age, due to the lack of sports programs adapted both to their medical conditions and to the constraints of dialysis (notably, having to remain in bed for several hours, several times a week). These limitations affect not only their cardiovascular function but also their quality of life.

Through the implementation of an Adapted Physical Activity (APA) program for dialysis patients, we aim to assess the potential benefits of this approach on muscle strength, functional abilities, cardiovascular health, and quality of life

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
15
Inclusion Criteria
  • Patient requiring hemodialysis sessions for end-stage renal disease
  • Patient aged between 5 and 20 years
  • Patient followed in the pediatric nephrology department at hospital Lyon (HFME : Hôpital Femme Mère Enfant)
  • Adult patient or parents/legal guardians informed about the study and having provided written consent for participation
  • Patient covered by a social security
Exclusion Criteria

Medical or surgical contraindications to adapted physical activity.

  • Persons deprived of liberty by judicial or administrative decision.
  • Persons undergoing psychiatric care.
  • Persons admitted to a healthcare or social facility for reasons other than research participation.
  • Adults under legal protection measures (curators)
  • Persons not affiliated with a social security scheme or beneficiaries of a similar system
  • Pregnant women.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
mass-to-muscle mass ratio between M0 and M6Between baseline (M0) and month 6 (M6)

Change in the mass-to-muscle mass ratio between M0 and M6, measured at the end of the hemodialysis session using bioelectrical impedance analysis.

Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.